De Ruysscher D - Search Results

1

The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?

De Ruysscher D, Vansteenkiste J, Belderbos J, Decaluwé H, Dingemans AM. De Ruysscher D, et al. J Thorac Oncol. 2016 Mar;11(3):284-6. doi: 10.1016/j.jtho.2016.01.003. J Thorac Oncol. 2016. PMID: 26922920 Free article. No abstract available.

2

Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.

Van den Brande P, De Ruysscher D, Vansteenkiste J, Spaas P, Specenier P, Demedts M. Van den Brande P, et al. Among authors: de ruysscher d. Lung Cancer. 1998 Oct;22(1):45-53. doi: 10.1016/s0169-5002(98)00071-3. Lung Cancer. 1998. PMID: 9869107 Clinical Trial.

3

Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects.

De Ruysscher D, Vansteenkiste J. De Ruysscher D, et al. Radiother Oncol. 2000 Apr;55(1):1-9. doi: 10.1016/s0167-8140(00)00156-0. Radiother Oncol. 2000. PMID: 10788682 Review.

4

Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.

De Ruysscher D, Lievens Y, Van den Brande P, Nackaerts K, Vansteenkiste J. De Ruysscher D, et al. Radiother Oncol. 2002 Jul;64(1):33-6. doi: 10.1016/s0167-8140(02)00144-5. Radiother Oncol. 2002. PMID: 12208572

5

Early versus late chest radiotherapy for limited stage small cell lung cancer.

Pijls-Johannesma MC, De Ruysscher D, Lambin P, Rutten I, Vansteenkiste JF. Pijls-Johannesma MC, et al. Among authors: de ruysscher d. Cochrane Database Syst Rev. 2005 Jan 25;2004(1):CD004700. doi: 10.1002/14651858.CD004700.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674960 Free PMC article. Review.

6

Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.

van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242

7

Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer.

De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P. De Ruysscher D, et al. Ann Oncol. 2006 Apr;17(4):543-52. doi: 10.1093/annonc/mdj094. Epub 2005 Dec 12. Ann Oncol. 2006. PMID: 16344277 Free article. Review.

8

Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.

De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P. De Ruysscher D, et al. J Clin Oncol. 2006 Mar 1;24(7):1057-63. doi: 10.1200/JCO.2005.02.9793. J Clin Oncol. 2006. PMID: 16505424

9

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, Rupa D, Pastorekova S, Stroobants S, Buell U, Lambin P, Vansteenkiste J, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Eur J Cancer. 2007 Jun;43(9):1392-8. doi: 10.1016/j.ejca.2007.03.027. Epub 2007 May 23. Eur J Cancer. 2007. PMID: 17512190

10

Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials.

Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J, Kester A, Rutten I, Lambin P. Pijls-Johannesma M, et al. Among authors: de ruysscher d. Cancer Treat Rev. 2007 Aug;33(5):461-73. doi: 10.1016/j.ctrv.2007.03.002. Epub 2007 May 21. Cancer Treat Rev. 2007. PMID: 17513057 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters